Scarica l'app Stockscreener
35.71
0.75%
-0.27
Precedente Chiudi:
$35.98
Aprire:
$36.2
Volume 24 ore:
2.54M
Relative Volume:
1.68
Capitalizzazione di mercato:
$8.15B
Reddito:
$5.30B
Utile/perdita netta:
$-624.00M
Rapporto P/E:
-11.63
EPS:
-3.0692
Flusso di cassa netto:
$42.00M
1 W Prestazione:
-2.16%
1M Prestazione:
+0.53%
6M Prestazione:
-18.00%
1 anno Prestazione:
-40.43%
Intervallo 1D:
$35.13
$36.82
Intervallo di 1 settimana:
$35.13
$36.94
Portata 52W:
$32.45
$62.30
Lineage Inc Stock (LINE) Company Profile
Nome
Lineage Inc
Settore
Industria
Telefono
(800) 678-7271
Indirizzo
46500 HUMBOLDT DRIVE, NOVI
Confronta LINE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LINE
Lineage Inc
|
35.71 | 8.21B | 5.30B | -624.00M | 42.00M | -3.0692 |
|
PLD
Prologis Inc
|
130.56 | 121.13B | 8.79B | 3.57B | 4.27B | 3.5567 |
|
PSA
Public Storage
|
276.19 | 48.68B | 4.79B | 1.91B | 2.93B | 9.6238 |
|
EXR
Extra Space Storage Inc
|
137.97 | 29.47B | 3.34B | 997.83M | 1.73B | 4.4718 |
|
EGP
Eastgroup Properties Inc
|
181.64 | 9.67B | 679.77M | 236.60M | 385.49M | 4.6371 |
|
REXR
Rexford Industrial Realty Inc
|
40.53 | 9.35B | 903.94M | 275.97M | 94.31M | 1.23 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-13 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-12-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-07-01 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-06-23 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-12 | Downgrade | BNP Paribas Exane | Neutral → Underperform |
| 2025-05-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-04-10 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-28 | Iniziato | Citigroup | Neutral |
| 2025-01-14 | Iniziato | Exane BNP Paribas | Neutral |
| 2024-12-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-09-18 | Iniziato | CapitalOne | Overweight |
| 2024-09-16 | Iniziato | CapitalOne | Overweight |
| 2024-08-19 | Iniziato | Deutsche Bank | Hold |
| 2024-08-19 | Iniziato | Evercore ISI | In-line |
| 2024-08-19 | Iniziato | Goldman | Buy |
| 2024-08-19 | Iniziato | JP Morgan | Overweight |
| 2024-08-19 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-08-19 | Iniziato | Mizuho | Neutral |
| 2024-08-19 | Iniziato | Morgan Stanley | Overweight |
| 2024-08-19 | Iniziato | Piper Sandler | Overweight |
| 2024-08-19 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-19 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-19 | Iniziato | Truist | Buy |
| 2024-08-19 | Iniziato | UBS | Neutral |
| 2024-08-19 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Lineage Inc Borsa (LINE) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Stockholders to Connect - Stockhouse
Lineage Focused on Bringing Certainty to Global Movement of Food - Nareit
Strs Ohio Lowers Holdings in Lineage, Inc. $LINE - MarketBeat
Is Lineage Inc. benefiting from innovation trends2025 Earnings Impact & Free Community Consensus Stock Picks - mfd.ru
Lineage, Inc. Announces Tax Treatment for 2025 Distributions - Yahoo Finance
Hedge Fund Moves: Can Lineage Cell Therapeutics Inc maintain sales growth2025 Volatility Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Lineage subsidiary proposes euro-denominated notes offering - MSN
U.S. Cold Storage Market to Reach US$ 91.4 Bn by 2032 as Key Players - openPR.com
Trade Report: Is Lineage Cell Therapeutics Inc a top pick in the sectorRisk Management & Verified Entry Point Detection - baoquankhu1.vn
Lineage, Inc. (NASDAQ:LINE) Given Average Recommendation of "Reduce" by Analysts - MarketBeat
Market Wrap: Can Lineage Inc deliver alphaDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
Market Moves: Is Lineage Cell Therapeutics Inc trading at a discountShare Buyback & Long-Term Safe Investment Plans - baoquankhu1.vn
What are the future prospects of Lineage Cell Therapeutics IncJuly 2025 Snapshot & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Guidance Update: Will Lineage Cell Therapeutics Inc stock hit new highs in YEARMarket Trend Review & Momentum Based Trading Signals - baoquankhu1.vn
Trade Recap: Will Lineage Cell Therapeutics Inc benefit from rising consumer demandTrade Exit Summary & Advanced Technical Signal Analysis - baoquankhu1.vn
Analysts Offer Insights on Real Estate Companies: Digital Realty (DLR) and Lineage, Inc. (LINE) - The Globe and Mail
What is Lineage Inc. s P E ratio telling usM&A Rumor & Safe Capital Growth Plans - mfd.ru
Lineage Therap Sells 12 Million Shares to Janus - MSN
Trading Recap: What are the analyst revisions for AFJKUIs Lineage Inc stock a good investment in YEARQuarterly Trade Review & Daily Oversold Bounce Ideas - baoquankhu1.vn
Aug Action: Can Lineage Inc be the next market leaderQuarterly Portfolio Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn
Aug Levels: Is GFL Environmental Inc stock showing strong momentum2025 Trading Recap & AI Based Trade Execution Alerts - baoquankhu1.vn
Travel Stocks: Can Lineage Inc outperform under higher oil pricesJuly 2025 Review & Community Driven Trade Alerts - baoquankhu1.vn
Assessing Lineage (LINE) Valuation As Analyst Downgrades Reset Market Expectations - simplywall.st
Lineage to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 25, 2026 - Business Wire
Market Overview: Should I average down on Lineage Cell Therapeutics Inc stockEarnings Trend Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Lineage (NASDAQ:LINE) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
The Bull Case For Lineage (LINE) Could Change Following Barclays Downgrade And Rising Analyst Caution - Sahm
Lineage Takes Delivery of Genetically Engineered iPSC Line with Hypoimmunity Edits from Factor Bioscience - BioInformant
Aug PostEarnings: Can Lineage Cell Therapeutics Inc stock outperform in 2025 bull market - moha.gov.vn
Lineage Shares Fall After Barclays Downgrade - marketscreener.com
Aug Sentiment: Will Lineage Inc stock deliver strong dividend growth2025 Valuation Update & Long Hold Capital Preservation Plans - moha.gov.vn
LINE: Barclays Downgrades Lineage, Lowers Price Target to $38.00 - GuruFocus
Lineage (NASDAQ:LINE) Given "Equal Weight" Rating at Barclays - MarketBeat
Barclays Downgrades Lineage to Equalweight From Overweight, Lowers Price Target to $38 From $47 - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Shareholders to Connect - ACCESS Newswire
Lineage, Inc. Reports Mixed Sentiment in Earnings Call - MSN
Aug Update: Why hedge funds are buying Lineage Inc stockTrade Entry Summary & Community Verified Swing Trade Signals - moha.gov.vn
Lineage, Inc. Prices €700M Senior Notes Offering - MSN
CEO Moves: Why Lineage Cell Therapeutics Inc stock remains a top recommendationMarket Movers & Verified Momentum Stock Alerts - moha.gov.vn
What dividend safety score for Lineage Cell Therapeutics Inc. stock2025 Geopolitical Influence & Safe Entry Point Alerts - ulpravda.ru
Why hedge funds are buying Lineage Inc. stockJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Shareholders to Reach Out - ACCESS Newswire
Will Lineage Inc. stock benefit from automationMarket Performance Recap & Risk Managed Investment Signals - ulpravda.ru
What dividend safety rating applies to Lineage Cell Therapeutics Inc. stock2025 Technical Overview & Target Return Focused Picks - ulpravda.ru
Why Lineage Cell Therapeutics Inc. stock is a must watch in 2025Earnings Beat & AI Powered Market Entry Strategies - ulpravda.ru
Earnings Miss: Can Lineage Cell Therapeutics Inc. stock resist sector downturnsJuly 2025 Gainers & Reliable Entry Point Trade Alerts - ulpravda.ru
CEO Change: What dividend safety rating applies to Lineage Cell Therapeutics Inc. stock2025 AllTime Highs & Daily Stock Trend Reports - ulpravda.ru
Can Lineage Inc. stock surprise with earnings upsideLow Beta Stocks & Free Superior Stock Performance - ulpravda.ru
US Cold Storage Market 2026-2033: Growth Overview, Facts & - openPR.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lineage, Inc. (LINE) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience - PharmiWeb.com
Lineage Inc Azioni (LINE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.21%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):